Eagle Asset Management Inc Axonics, Inc. Transaction History

Eagle Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$49.38 - $63.75 $292,329 - $377,400	-5,920 Reduced 3.77%	151,268 $9.41 Million
Q3 2023 Nov 13, 2023	SELL	$48.64 - $62.51 $10.6 Million - $13.6 Million	-217,157 Reduced 58.01%	157,188 $8.82 Million
Q2 2023 Aug 09, 2023	SELL	$47.99 - $60.21 $544,878 - $683,624	-11,354 Reduced 2.94%	374,345 $18.9 Million
Q1 2023 May 08, 2023	BUY	$52.6 - $67.34 $1.16 Million - $1.48 Million	22,018 Added 6.05%	385,699 $21 Million
Q4 2022 Feb 14, 2023	BUY	$59.56 - $76.6 $533,538 - $686,182	8,958 Added 2.53%	363,681 $22.7 Million
Q3 2022 Nov 07, 2022	BUY	$57.96 - $78.12 $14.5 Million - $19.5 Million	249,443 Added 236.93%	354,723 $25 Million
Q2 2022 Aug 10, 2022	SELL	$39.5 - $64.42 $6,122 - $9,985	-155 Reduced 0.15%	105,280 $5.97 Million
Q1 2022 May 12, 2022	SELL	$43.74 - $62.76 $207,677 - $297,984	-4,748 Reduced 4.31%	105,435 $6.6 Million
Q4 2021 Feb 11, 2022	SELL	$50.01 - $73.35 $678,935 - $995,799	-13,576 Reduced 10.97%	110,183 $6.19 Million
Q3 2021 Nov 10, 2021	SELL	$59.21 - $78.66 $954,465 - $1.27 Million	-16,120 Reduced 11.52%	123,759 $8.06 Million
Q2 2021 Aug 11, 2021	SELL	$51.39 - $66.9 $279,715 - $364,136	-5,443 Reduced 3.75%	139,879 $8.87 Million
Q1 2021 May 14, 2021	BUY	$49.14 - $59.89 $622,308 - $758,446	12,664 Added 9.55%	145,322 $8.52 Million
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $3.28 Million - $4 Million	77,735 Added 141.53%	132,658 $6.62 Million
Q3 2020 Nov 12, 2020	BUY	$35.33 - $51.04 $1.94 Million - $2.8 Million	54,923 New	54,923 $2.71 Million

10.1M

5.2K

58.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.